top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Prescription drugs [[electronic resource] ] : drug company programs help some people who lack coverage : report to congressional requesters
Prescription drugs [[electronic resource] ] : drug company programs help some people who lack coverage : report to congressional requesters
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. General Accounting Office, , [2000]
Soggetto topico Pharmaceutical industry - United States
Medically uninsured persons - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Prescription drugs
Record Nr. UNINA-9910692537203321
[Washington, D.C.] : , : U.S. General Accounting Office, , [2000]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Prescription for the People : An Activist’s Guide to Making Medicine Affordable for All / / Fran Quigley
Prescription for the People : An Activist’s Guide to Making Medicine Affordable for All / / Fran Quigley
Autore Quigley Fran <1962->
Pubbl/distr/stampa Ithaca : , : ILR Press, an imprint of Cornell University Press, , 2017
Descrizione fisica 1 online resource (260 pages)
Disciplina 338.4/36150973
Collana The culture and politics of health care work
Soggetto topico Health care reform - United States
Pharmaceutical industry - United States
Pharmaceutical policy - United States
Drug accessibility - United States
Prescription pricing - United States
Drugs - Prices - United States
Soggetto genere / forma Electronic books.
ISBN 1-5017-1391-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto People everywhere are struggling to get the medicines they need -- The United States has a drug problem -- Millions of people are dying needlessly -- Cancer patients face particularly deadly barriers to medicines -- The current medicine system neglects many major diseases -- Corporate research and development investments are exaggerated -- The current system wastes billions on drug marketing -- The current system compromises physician integrity and leads to unethical corporate behavior -- Medicines are priced at whatever the market will bear -- Pharmaceutical corporations reap history-making profits -- The for-profit medicine arguments are patently false -- Medicine patents are extended too far and too wide -- Patent protectionism stunts the development of new medicines -- Governments, not private corporations, drive medicine innovation -- Taxpayers and patients pay twice for patented medicines -- Medicines are a public good -- Medicine patents are artificial, recent, and government-created -- The United States and big pharma play the bully in extending patents -- Pharma-pushed trade agreements steal the power of democratically elected governments -- Current law provides opportunities for affordable generic medicines -- There is a better way to develop medicines -- Human rights law demands access to essential medicines.
Record Nr. UNINA-9910466810103321
Quigley Fran <1962->  
Ithaca : , : ILR Press, an imprint of Cornell University Press, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Prescription for the People : An Activist’s Guide to Making Medicine Affordable for All / / Fran Quigley
Prescription for the People : An Activist’s Guide to Making Medicine Affordable for All / / Fran Quigley
Autore Quigley Fran <1962->
Pubbl/distr/stampa Ithaca : , : ILR Press, an imprint of Cornell University Press, , 2017
Descrizione fisica 1 online resource (260 pages)
Disciplina 338.4/36150973
Collana The culture and politics of health care work
Soggetto topico Health care reform - United States
Pharmaceutical industry - United States
Pharmaceutical policy - United States
Drug accessibility - United States
Prescription pricing - United States
Drugs - Prices - United States
Soggetto genere / forma Electronic books.
ISBN 1-5017-1391-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto People everywhere are struggling to get the medicines they need -- The United States has a drug problem -- Millions of people are dying needlessly -- Cancer patients face particularly deadly barriers to medicines -- The current medicine system neglects many major diseases -- Corporate research and development investments are exaggerated -- The current system wastes billions on drug marketing -- The current system compromises physician integrity and leads to unethical corporate behavior -- Medicines are priced at whatever the market will bear -- Pharmaceutical corporations reap history-making profits -- The for-profit medicine arguments are patently false -- Medicine patents are extended too far and too wide -- Patent protectionism stunts the development of new medicines -- Governments, not private corporations, drive medicine innovation -- Taxpayers and patients pay twice for patented medicines -- Medicines are a public good -- Medicine patents are artificial, recent, and government-created -- The United States and big pharma play the bully in extending patents -- Pharma-pushed trade agreements steal the power of democratically elected governments -- Current law provides opportunities for affordable generic medicines -- There is a better way to develop medicines -- Human rights law demands access to essential medicines.
Record Nr. UNINA-9910528815803321
Quigley Fran <1962->  
Ithaca : , : ILR Press, an imprint of Cornell University Press, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2020
Descrizione fisica 1 online resource (v, 97 pages) : illustrations
Soggetto topico Insulin - Cost control
Prescription pricing - Government policy - United States
Pharmaceutical industry - United States
Drugs - United States - Cost control
Drugs - Prices - Government policy - United States
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Priced out of a Lifesaving Drug
Record Nr. UNINA-9910717377703321
Washington : , : U.S. Government Publishing Office, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
El proceso del desarrollo de las drogas y la FDA [[electronic resource] ] : cómo la agencia asegura que las drogas sean seguras y efectivas
El proceso del desarrollo de las drogas y la FDA [[electronic resource] ] : cómo la agencia asegura que las drogas sean seguras y efectivas
Pubbl/distr/stampa Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, , [2002]
Descrizione fisica 1 sheet : digital, PDF file
Collana Just the facts
Publication
Soggetto topico Drug development
Drugs - Testing
Pharmaceutical industry - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione spa
Altri titoli varianti Proceso del desarrollo de las drogas y la FDA
Record Nr. UNINA-9910695445703321
Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, , [2002]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recommendation followup memorandum report : states' collection of rebates for drugs paid through Medicaid managed care organizations has improved
Recommendation followup memorandum report : states' collection of rebates for drugs paid through Medicaid managed care organizations has improved
Pubbl/distr/stampa Washington, DC : , : Department of Health and Human Services, Office of Inspector General, , 2012
Descrizione fisica 1 online resource (11 pages) : illustrations
Soggetto topico Medicaid - Auditing
Accountable care organizations (Medical care) - United States
Pharmaceutical services insurance - United States
Pharmaceutical industry - United States
Rebates - United States
Pharmaceutical policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Recommendation followup memorandum report
Record Nr. UNINA-9910707495603321
Washington, DC : , : Department of Health and Human Services, Office of Inspector General, , 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013
Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 2014
Descrizione fisica 1 online resource (vi, 190 pages)
Soggetto topico Drugs - Dosage forms - United States
Pharmaceutical industry - United States
Drug adulteration - United States - Prevention
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Reforming the drug compounding regulatory framework
Record Nr. UNINA-9910702554703321
Washington : , : U.S. Government Printing Office, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
States' collection of Medicaid rebates for physician-administered drugs
States' collection of Medicaid rebates for physician-administered drugs
Pubbl/distr/stampa [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2011
Descrizione fisica 1 online resource (v, 43 pages) : illustrations
Soggetto topico Medicaid - Auditing
Accountable care organizations (Medical care) - United States
Pharmaceutical services insurance - United States
Pharmaceutical industry - United States
Rebates - United States
Pharmaceutical policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti States' collection of Medicaid rebates for physician-administered drugs
Record Nr. UNINA-9910707233503321
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
States' collection of rebates for drugs paid through Medicaid managed care organizations
States' collection of rebates for drugs paid through Medicaid managed care organizations
Pubbl/distr/stampa [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2012
Descrizione fisica 1 online resource (26 pages) : illustrations
Soggetto topico Medicaid - Auditing
Accountable care organizations (Medical care) - United States
Pharmaceutical services insurance - United States
Pharmaceutical industry - United States
Rebates - United States
Pharmaceutical policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti States' collection of Medicaid rebates for drugs paid through Medicaid managed care organizations
Collection of rebates for drugs paid through Medicaid MCOs
Record Nr. UNINA-9910707250203321
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
To America's health : a proposal to reform the Food and Drug Administration / / Henry I. Miller
To America's health : a proposal to reform the Food and Drug Administration / / Henry I. Miller
Autore Miller Henry I
Pubbl/distr/stampa Stanford, California : , : Hoover Institution Press, , 2000
Descrizione fisica 1 online resource (128 p.)
Disciplina 353.9/98/0973
Collana Hoover Institution Press publication
Soggetto topico Pharmaceutical policy - United States
Drugs - Law and legislation - United States
Pharmaceutical industry - United States
Soggetto genere / forma Electronic books.
ISBN 0-8179-9908-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto part I. The need for fundamental food and drug administration reform -- part II. A model for reform of the food and drug administration.
Record Nr. UNINA-9910453470703321
Miller Henry I  
Stanford, California : , : Hoover Institution Press, , 2000
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui